A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Travere Therapeutics, Inc.
- Study ID
- NCT06247085
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Homocystinuria
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Pegtibatinase — DRUGPegtibatinase BIW
- Placebo — OTHERvolume-matched saline SC BIW
Study Details
The purpose of this study is to measure efficacy and safety of pegtibatinase treatment compared with placebo in participants with classical HCU receiving standard of care. Study details include: * Total Study duration: up to 38 weeks * Screening: * Initial Screening duration: up to 4 weeks * Pre-treatment Diet Standardization Period duration: up to 6 weeks * Blinded Treatment Duration: 24 weeks * 2-week blinded dose titration period * 22-week blinded assessment period * Safety Follow-Up: 4 weeks after last dose (as applicable for those not enrolling in the long term extension study, ENSEMBLE)
Key Dates
- Start date
- Dec 28, 2023
- Status verified
- May 2026
- Primary completion
- Aug 31, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 70 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: pegtibatinase
- Placebo Comparator: placebo
Primary Outcome Measure
Change from baseline in plasma tHcy levels - Weeks 6 to 12 [ Time Frame: Weeks 6 - 12 ]
Central Contacts
- Travere Call Center1-877-659-5518
Locations (13)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Phoenix Children's Hospital | Phoenix | Arizona | 85006 | - |
| Yale University School of Medicine | New Haven | Connecticut | 06519 | - |
| Emory University | Atlanta | Georgia | 30322 | - |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | - |
| Maine Health - Maine Medical Center | Portland | Maine | 04102 | - |
| Uncommon Cures | Chevy Chase | Maryland | 20815 | - |
| The Mount Sinai Hospital | New York | New York | 10029 | - |
| Science 37 - Virtual Site | Morrisville | North Carolina | 27560 | - |
| Oregon Health and Science University | Portland | Oregon | 97239 | - |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | - |
| University of Pittsburgh Medical Center - Children's Hospital of Pittsburgh | Pittsburgh | Pennsylvania | 15224 | - |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | - |
| Utah Health - The University of Utah Primary Children's Hospital | Salt Lake City | Utah | 84113 | - |
Find similar trials in Phoenix, AZ
Related Studies
- Early Check: Expanded Screening in NewbornsEnrolling By Invitation · RTI International · Research Triangle Park, North Carolina
- A Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE)PHASE3 · Enrolling By Invitation · Travere Therapeutics, Inc. · Phoenix, Arizona